LPL Financial
DMAC icon

LPL Financial’s DiaMedica Therapeutics DMAC Stock Holding History

LPL Financial’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64M Buy
233,500
+7,450
+3% +$45.8K ﹤0.01% 3971
2026
Q1 		$1.53M Buy
226,050
+28,900
+15% +$229K ﹤0.01% 3758
2025
Q4 		$1.57M Sell
197,150
-6,000
-3% -$44.9K ﹤0.01% 3618
2025
Q3 		$1.4M Buy
203,150
+5,650
+3% +$30.6K ﹤0.01% 3664
2025
Q2 		$770K Buy
197,500
+42,200
+27% +$165K ﹤0.01% 3992
2025
Q1 		$589K Buy
155,300
+3,300
+2% +$18.9K ﹤0.01% 4019
2024
Q4 		$825K Buy
152,000
+11,500
+8% +$54.2K ﹤0.01% 3664
2024
Q3 		$589K Buy
140,500
+123,000
+703% +$454K ﹤0.01% 3858
2024
Q2 		$51.6K Buy
+17,500
New +$48K ﹤0.01% 4835

Other funds holding DMAC

CLG
Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

LPL Financial's DMAC Position: Q2 2026 in Review

LPL Financial increased its DiaMedica Therapeutics (DMAC) stake by 3.3% in Q2 2026, buying an estimated $45.8K and bringing the position to 233,500 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #3971.

LPL Financial first reported a position in DMAC in Q2 2024 and has held it in 9 quarters since. 89 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

  • LPL Financial held 233,500 shares of DiaMedica Therapeutics worth $1.64M as of Q2 2026.
  • LPL Financial bought 7,450 DiaMedica Therapeutics shares in Q2 2026, an estimated $45.8K.
  • DiaMedica Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #3971 holding.
  • LPL Financial first reported a position in DiaMedica Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 89 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.